Literature DB >> 27147064

Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study.

Marlene Bloechliger1, Alessandro Ceschi2,3, Stephan Rüegg4, Susan Sara Jick5, Christoph Rudolf Meier6,7,8, Michael Bodmer1,9.   

Abstract

To investigate risk factors for incident seizures among adult patients with depression. We conducted a nested case-control analysis in adult patients with newly diagnosed depression, using data from the U.K.-based Clinical Practice Research Datalink. Among cases with incident seizures and matched controls, we estimated odds ratios (ORs) with 95 % confidence intervals (CIs) of potential risk factors for seizures as reported from data of the general population: underweight (body mass index <18.5 kg/m2), smoking, alcoholism, drug abuse, psychiatric or neurologic comorbidities, and concomitant use of drugs. Of 186,540 patients with depression, 1489 developed a seizure during follow-up. Being underweight (OR 1.67 [95 % CI 1.23-2.26]), a current smoker (OR 1.45 [95 % CI 1.26-1.67]), having alcoholism (OR 2.98 [95 % CI 2.56-3.47]), and drug abuse (OR 2.51 [95 % CI 1.94-3.24]), were associated with increased risks of seizures compared to normal weight, non-smoking, no alcoholism, and no drug abuse, respectively. Previous stroke/transient ischemic attack (OR 6.07 [95 % CI 4.71-7.83]) or intracerebral bleeding (OR 8.19 [95 % CI 4.80-13.96]), and comorbid dementia (OR 6.83 [95 % CI 4.81-9.69]), were strongly associated with seizures. Current use of cephalosporins (OR 2.47 [95 % CI 1.61-3.78]) and antiarrhythmics (OR 1.59 [95 % CI 1.26-2.01]) was associated with an increased risk of seizures compared to non-use. Among adult patients with depression, being underweight, smoking, alcoholism, and drug abuse, were associated with seizures. Remote stroke and comorbid dementia were strong risk factors for seizures. Current use of cephalosporins or antiarrhytmics was associated with an increased risk of seizures compared to non-use.

Entities:  

Keywords:  Depression; Depressive disorder; Risk factors; Seizures

Mesh:

Year:  2016        PMID: 27147064     DOI: 10.1007/s10654-016-0156-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

1.  Major depression is a risk factor for seizures in older adults.

Authors:  D C Hesdorffer; W A Hauser; J F Annegers; G Cascino
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

Review 2.  Epileptogenic drugs: a systematic review.

Authors:  Claudio Ruffmann; Graziella Bogliun; Ettore Beghi
Journal:  Expert Rev Neurother       Date:  2006-04       Impact factor: 4.618

Review 3.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project.

Authors:  J Burn; M Dennis; J Bamford; P Sandercock; D Wade; C Warlow
Journal:  BMJ       Date:  1997-12-13

Review 5.  Drug treatment of epilepsy in adults.

Authors:  Dieter Schmidt; Steven C Schachter
Journal:  BMJ       Date:  2014-02-28

Review 6.  Seizures and schizophrenia.

Authors:  T M Hyde; D R Weinberger
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

Review 7.  Management of the first seizure: an evidence based approach.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2009-12       Impact factor: 2.401

8.  Prevalence of acute repetitive seizures (ARS) in the United Kingdom.

Authors:  Carlos Martinez; Tim Sullivan; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-09-11       Impact factor: 3.045

Review 9.  [Drug-induced seizures].

Authors:  F Block; M Dafotakis
Journal:  Fortschr Neurol Psychiatr       Date:  2012-11-08       Impact factor: 0.752

10.  Population-based study of seizure disorders after cerebral infarction.

Authors:  E L So; J F Annegers; W A Hauser; P C O'Brien; J P Whisnant
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

View more
  3 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

2.  Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.

Authors:  John Busby; Ken Mills; Shu-Dong Zhang; Fabio Giuseppe Liberante; Chris R Cardwell
Journal:  Breast Cancer Res       Date:  2018-01-19       Impact factor: 6.466

Review 3.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.